Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Inhibiteur phosphodiesterase")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 262

  • Page / 11
Export

Selection :

  • and

The inhibitory profile of ibudilast against the human phosphodiesterase enzyme familyGIBSON, Lucien C. D; HASTINGS, Stuart F; MCPHEE, Ian et al.European journal of pharmacology. 2006, Vol 538, Num 1-3, pp 39-42, issn 0014-2999, 4 p.Article

Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitorsDRESSER, M. J; DESAI, D; GIDWANI, S et al.International journal of impotence research. 2006, Vol 18, Num 1, pp 104-110, issn 0955-9930, 7 p.Article

Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors : Focus on «-blocker interactionsKLONER, Robert A.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 42M-46M, issn 0002-9149Conference Paper

Treatment for erectile dysfunction based on patient-reported outcomes : To every man the PDE5 inhibitor that he finds superiorHEDELIN, Hans; STRÖBERG, Peter.Drugs (Basel). 2005, Vol 65, Num 16, pp 2245-2251, issn 0012-6667, 7 p.Article

Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulationSATO, Yukio; HIRAMATSU, Yuji; HOMMA, Satoshi et al.Journal of thoracic and cardiovascular surgery. 2005, Vol 130, Num 2, pp 346-350, issn 0022-5223, 5 p.Article

Evaluation of tableting and tablet properties of kollidon SR : The influence of moisture and mixtures with theophylline monohydrateHAUSCHILD, Karsten; PICKER-FREYER, Katharina M.Pharmaceutical development and technology. 2006, Vol 11, Num 1, pp 125-140, issn 1083-7450, 16 p.Article

Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lambJAILLARD, Sophie; LARRUE, Benoit; DERUELLE, Philippe et al.The Annals of thoracic surgery. 2006, Vol 81, Num 3, pp 935-942, issn 0003-4975, 8 p.Article

Intoxication à la théophyllineWINDY, M; CHAFIQ, F; RALEM, N et al.Espérance médicale. 2005, Vol 12, Num 122, pp 566-568, 3 p.Article

Cardiac safety in clinical trials of phosphodiesterase 5 inhibitorsCARSON, Culley C.The American journal of cardiology. 2005, Vol 96, Num 12B, pp 37M-41M, issn 0002-9149Conference Paper

Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated applicationHARADA, Daisuke; TSUKUMO, Yukihito; TAKASHIMA, Yuko et al.European journal of pharmacology. 2006, Vol 532, Num 1-2, pp 128-137, issn 0014-2999, 10 p.Article

The potential role of roflumilast : The new phosphodiesterase-4 inhibitorKARISH, Sarah B; GAGNON, James M.The Annals of pharmacotherapy. 2006, Vol 40, Num 6, pp 1096-1104, issn 1060-0280, 9 p.Article

Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit : Two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteersHOUGHTON, Lesley A; ATKINSON, Wendy; WHORWELL, Peter J et al.Clinical therapeutics. 2006, Vol 28, Num 4, pp 569-581, issn 0149-2918, 13 p.Article

INHIBITION OF METABOLIC EFFECTS OF GROWTH HORMONE BY VARIOUS INHIBITORS OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASERILLEMA JA; KOSTYO JL; GIMPEL LP et al.1973; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1973; VOL. 297; NO 2; PP. 527-539; BIBL. 17REF.Article

Screening suspected counterfeit Viagra® and imitations of Viagra® with near-infrared spectroscopyVREDENBREGT, M. J; BLOK-TIP, L; HOOGERBRUGGE, R et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 40, Num 4, pp 840-849, issn 0731-7085, 10 p.Article

Short-term use of sildenafil in the treatment of unconsumated marriagesGHANEM, H; ZAAZAA, A; KAMEL, I et al.International journal of impotence research. 2006, Vol 18, Num 1, pp 52-54, issn 0955-9930, 3 p.Article

Use of sildenafil for female sexual dysfunctionSHIELDS, Kelly M; HROMETZ, Sandra L.The Annals of pharmacotherapy. 2006, Vol 40, Num 5, pp 931-934, issn 1060-0280, 4 p.Article

Are phosphodiesterase 4 inhibitors just more theophylline?BOSWELL-SMITH, Victoria; CAZZOLA, Mario; PAGE, Clive P et al.Journal of allergy and clinical immunology. 2006, Vol 117, Num 6, pp 1237-1243, issn 0091-6749, 7 p.Article

Effect of sildenafil citrate on postprandial gallbladder motilityDEGIRMENCI, Bumin; ACAR, Murat; ALBAYRAK, Ramazan et al.Southern medical journal (Birmingham). 2006, Vol 99, Num 3, pp 208-211, issn 0038-4348, 4 p.Article

Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver : results of a pilot studyDEIBERT, P; SCHUMACHER, Y.-O; RUECKER, G et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 1, pp 121-128, issn 0269-2813, 8 p.Article

Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamineORLANDO, Rocco; PADRINI, Roberto; PERAZZI, Mauro et al.Clinical pharmacology and therapeutics. 2006, Vol 79, Num 5, pp 489-499, issn 0009-9236, 11 p.Article

Sex and the heartSCHWARZ, E. R; RODRIGUEZ, J.International journal of impotence research. 2005, Vol 17, pp S4-S6, issn 0955-9930, SUP1Conference Paper

Characterization of calcium alginate beads containing structurally similar drugsSMRDEL, P; BOGATAJ, M; PODLOGAR, F et al.Drug development and industrial pharmacy. 2006, Vol 32, Num 5, pp 623-633, issn 0363-9045, 11 p.Article

Controlled release by permeability alteration of cationic ammonio methacrylate copolymers using ionic interactionsRAVISHANKAR, H; PATIL, P; SAMEL, A et al.Drug development and industrial pharmacy. 2006, Vol 32, Num 6, pp 709-718, issn 0363-9045, 10 p.Article

Phosphodiesterase 4 inhibitor rolipram potentiates the inhibitory effect of calcitonin on osteoclastogenesisMIYAMOTO, Ken-Ichi; NISHIOKA, Tatsuo; WAKI, Yoshihiro et al.Journal of bone and mineral metabolism (English ed.). 2006, Vol 24, Num 4, pp 260-265, issn 0914-8779, 6 p.Article

The canine CYP1A2 deficiency polymorphism dramatically affects the pharmacokinetics of 4-cyclohexyl-1-ethyl-7-methylpyrido[2,3-D]-pyrimidine-2-(1H)-one (YM-64227), a phosphodiesterase type 4 inhibitorTENMIZU, Daisuke; NOGUCHI, Kiyoshi; KAMIMURA, Hidetaka et al.Drug metabolism and disposition. 2006, Vol 34, Num 5, pp 800-806, issn 0090-9556, 7 p.Article

  • Page / 11